We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods

By LabMedica International staff writers
Posted on 19 Nov 2019
Print article
Image: Fully automatic analyzer for immunoblot and westernblot methods (Photo courtesy of Dynex Technologies)
Image: Fully automatic analyzer for immunoblot and westernblot methods (Photo courtesy of Dynex Technologies)
DYNEX Technologies (Prague, Czech Republic) demonstrated its DYNABLOT automatic analyzer for immunoblot and Western blot methods at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 18-21 November in Düsseldorf, Germany. At the 2019 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

The increasing digitalization of processes in the healthcare economy was a major topic at this year's MEDICA and was represented by exhibitors at the event as well as reflected in the programs of the accompanying conferences and forums. A new feature this year was a new allocation of themes in the exhibition halls. Due to the increasing convergence of software and hardware, especially in the field of medical technology, the halls for the MEDICA segment of information and communication technology was moved to make it directly connected to the halls for medical technology and electromedicine. Manufacturers of surgical instruments were moved to halls that brought them thematically closer to providers of imaging technology (e.g. endoscopy) as well as complete solutions for modern hybrid operating rooms.

DYNEX, a supplier of laboratory equipment and related services, primarily focuses on the sale of instruments, diagnostics and other reagents for immunochemical, molecular-biological and microbiological laboratories. DYNEX specializes in the following methods: ELISA, immunoblot and Western blot, immunofluorescence assay (IFA), PCR, hybridization, electrophoresis, microarray, next-generation sequencing, lateral-flow immunoassay (LFIA), immunoprecipitation, cultivation and cell growth curves measurements.

At the 2019 edition of MEDICA, DYNEX demonstrated its DYNABLOT fully automated analyzer for immunoblot and Western blot methods. The system fully automates blot pro- cessing starting with samples being pipetted and finishes with camera image capture. Only insertion of samples in primary tubes and strips are required from an operator. The instrument is fitted with reagents peristaltic pumps located at its front for easy use and handling. The pumps are capable of running in reverse. It assists the functions “Antidrop” (no drops at the end of tubing during dispensing) and “Reagents saving” (aspiration of dead volume back to reagent bottles after last dis-pensing).

The mixing of strip content during incubation is assisted by rocking the strip plate. Slow, medium or fast rocking speeds can be selected. Used liquid media is removed by an integrated vacuum pump and then directed to a waste bottle with a level sensor. Its compact dimensions (800 x 500 x 540 mm), weight (35 kg), and very quiet running make it friendly to laboratory environments.

Related Links:
Dynex Technologies

Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Echinococcus Granulosus Assay
Echinococcus Granulosus IgG ELISA
New
Moxifloxacin Resistance Assay
Allplex MG & MoxiR Assay

Print article

Channels

Microbiology

view channel
Image: The breakthrough system offers a faster way to diagnose bloodborne infections (Photo courtesy of Melio)

Culture-Free Platform Rapidly Identifies Blood Stream Infections

Neonatal sepsis is a life-threatening condition that results from bloodstream infections in newborns under 28 days old. Due to their immature immune systems, newborns are especially vulnerable to infections.... Read more

Pathology

view channel
Image: The technique predicts how well some breast cancer patients will respond to chemotherapy (Photo courtesy of Shutterstock)

New Technique Predicts Tumor’s Responsiveness to Breast Cancer Treatment

Breast cancer is the most common cancer among women worldwide, with 2.3 million new cases diagnosed each year. In the era of personalized medicine, targeted therapies for different types of breast cancer... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.